Corbus Pharmaceuticals Holdings Inc (CRBP) stock has gained 20.82% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives CRBP stock a score of 88 out of a possible 100.
That score is chiefly influenced by a long-term technical score of 93. CRBP’s score also includes a short-term technical score of 86. The fundamental score for CRBP is 84. In addition to the average rating from Wall Street analysts, CRBP stock has a mean target price of $25.00. This means analysts expect the stock to increase 239.21% over the next 12 months.
What’s Happening with CRBP Stock Today
Corbus Pharmaceuticals Holdings Inc (CRBP) stock is lower by -5.54% while the S&P 500 has fallen -0.24% as of 12:35 PM on Monday, Apr 8. CRBP has fallen -$0.43 from the previous closing price of $7.80 on volume of 1,316,712 shares. Over the past year the S&P 500 has risen 10.44% while CRBP has gained 20.82%. CRBP lost -$0.98 per share the over the last 12 months.